Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

# AGENCY:

Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.

# ACTION:

Notice.

# SUMMARY:

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a virtual meeting. The meeting will be open to the public and public comment will be heard during the meeting.

# DATES:

                        The meeting will be held September 14-15, 2021. The confirmed meeting times and agenda will be posted on the NVAC website at                         *http://www.hhs.gov/​nvpo/​nvac/​meetings/​index.html*                         as soon as they become available.                    

# ADDRESSES:

                        Instructions regarding attending this meeting will be posted online at:                         *http://www.hhs.gov/​nvpo/​nvac/​meetings/​index.html*                         at least one week prior to the meeting. Pre-registration is required for those who wish to attend the meeting or participate in public comment. Please register at                         *http://www.hhs.gov/​nvpo/​nvac/​meetings/​index.html.*

# FOR FURTHER INFORMATION CONTACT:

                        Ann Aikin, Acting Designated Federal Officer, at the Office of Infectious Disease and HIV/AIDS Policy, U.S. Department of Health and Human Services, Mary E. Switzer Building, Room L618, 330 C Street SW, Washington, DC 20024. Email:                         *nvac@hhs.gov.*                         Phone: 202-494-1719.                    

# SUPPLEMENTARY INFORMATION:

Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program's responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program.

                    During this NVAC meeting, NVAC will hear presentations on vaccine safety, vaccine development, and communication activities. Please note that agenda items are subject to change, as priorities dictate. Information on the final meeting agenda will be posted prior to the meeting on the NVAC website:                     *http://www.hhs.gov/​nvpo/​nvac/​index.html.*

                    Members of the public will have the opportunity to provide comment at the NVAC meeting during the public comment period designated on the agenda. Public comments made during the meeting will be limited to three minutes per person to ensure time is allotted for all those wishing to speak. Individuals are also welcome to submit written comments in advance. Written comments should not exceed three pages in length. Individuals submitting comments should email their written comments or their request to provide a comment during the meeting to                     *nvac@hhs.gov*                     at least five business days prior to the meeting.                

Dated: August 19, 2021.

Ann Aikin,

Acting Designated Federal Official, Office of the Assistant Secretary for Health.

[FR Doc. 2021-18809 Filed 8-31-21; 8:45 am]

BILLING CODE 4150-44-P